Skip to main content
. 2020 Aug 5;9(8):2526. doi: 10.3390/jcm9082526

Figure 2.

Figure 2

Initial study evaluating the biochemical efficacy of AAT augmentation therapy. Reproduced with permission from Reference [6]. (A) The response of serum al-antitrypsin levels to the infusion of 4.0 g of AAT. (B) Serum neutrophil elastase inhibitory activity following weekly intravenous infusions of 4.0 g of AAT. (C) Lower respiratory tract al-antitrypsin levels during intravenous replacement therapy with 4.0 g of AAT. (D) Lower respiratory tract neutrophil elastase inhibitory activity following weekly intravenous infusions of 4.0 g of AAT.